Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hyperfine, Inc. - Class A Common Stock (NQ: HYPR )

0.9799 -0.0001 (-0.01%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Hyperfine, Inc. - Class A Common Stock

< Previous 1 2 Next >
Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024
From Hyperfine, Inc.
Via Business Wire
Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation
From Hyperfine, Inc.
Via Business Wire
Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care
From Hyperfine, Inc.
Via Business Wire
Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Revenue Guidance
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer's Patients
From Hyperfine, Inc.
Via Business Wire
Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images
From Hyperfine, Inc.
Via Business Wire
Portable MRI as a Tissue Clock for Acute Ischemic Stroke: Multi-Site Study to be Published in August 2024 Edition of Annals of Neurology Shows the Value of the Ultra-Low-Field Swoop® Portable MR Imaging® System in Acute Stroke Diagnosis
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024
From Hyperfine, Inc.
Via Business Wire
Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners
From Hyperfine, Inc.
Via Business Wire
Clinical Research Using Swoop® System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimer’s Association International Conference
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop® System to India
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Present at the Jefferies Global Healthcare Conference
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Celebrates ASNR 2024
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Reports First Quarter 2024 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
From Hyperfine, Inc.
Via Business Wire
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
From Hyperfine, Inc.
Via GlobeNewswire
Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use
From Hyperfine, Inc.
Via Business Wire
Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023
From Hyperfine, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.